Guangwen Shu
- Pharmacology top 2%
- Cancer Research top 10%
- NF-κB Signaling Pathways 5
- Biochemistry top 5%
- Molecular Biology top 10%
- Genomics, phytochemicals, and oxidative stress 8
- Natural product bioactivities and synthesis 7
- Bioactive natural compounds 4
-
- Natural Antidiabetic Agents Studies 4
-
- Liver physiology and pathology 6
-
- Liver Disease Diagnosis and Treatment 6
-
- Chromatography in Natural Products 5
- Journals
- Nature (1 paper)Journal of Agricultural and Food Chemistry (3 papers)Cell Death and Differentiation (1 paper)
- Partner nations
- ChinaIndiaSouth Korea
In The Last Decade
Guangwen Shu
41 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 102
- Pharmacology 223
- Cancer Research 238
- Biochemistry 91
- Molecular Biology 919
- Endocrinology, Diabetes and Metabolism 204
Countries citing papers authored by Guangwen Shu
This map shows the geographic impact of Guangwen Shu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guangwen Shu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guangwen Shu more than expected).
Fields of papers citing papers by Guangwen Shu
This network shows the impact of papers produced by Guangwen Shu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guangwen Shu. The network helps show where Guangwen Shu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Guangwen Shu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 11 | |
| 2 | 2023 | 11 | |
| 3 | 2023 | 9 | |
| 4 | 2023 | 8 | |
| 5 | 2022 | 22 | |
| 6 | 2021 | 19 | |
| 7 | 2021 | 27 | |
| 8 | 2020 | 19 | |
| 9 | 2018 | 54 | |
| 10 | 2018 | 43 | |
| 11 | 2015 | 28 | |
| 12 | 2015 | 54 | |
| 13 | 2015 | 33 | |
| 14 | 2014 | 48 | |
| 15 | 2014 | 25 | |
| 16 | 2013 | 26 | |
| 17 | 2013 | 40 | |
| 18 | 2013 | 31 | |
| 19 | 2011 | 136 | |
| 20 | 2010 | 127 |
About Guangwen Shu
Guangwen Shu is a scholar working on Pharmacology, Hepatology and Cancer Research, having authored 41 papers that have together received 1.5k indexed citations. Recurring topics across this work include Genomics, phytochemicals, and oxidative stress (8 papers), Natural product bioactivities and synthesis (7 papers), Liver physiology and pathology (6 papers), Liver Disease Diagnosis and Treatment (6 papers), Chromatography in Natural Products (5 papers), NF-κB Signaling Pathways (5 papers), Natural Antidiabetic Agents Studies (4 papers) and Bioactive natural compounds (4 papers). The work is most often cited by research in Pharmacology (223 citations), Cancer Research (238 citations) and Biochemistry (91 citations). Guangwen Shu has collaborated with scholars based in China, India and South Korea. Frequent co-authors include Xukun Deng, Jianguo Song, Xinzhou Yang, Xinwang Yuan, Ji Hao, Zhinan Mei, Ling Yue, Naihe Jing, Tao Zheng and Yin Zhao. Their work appears in journals such as Nature, Journal of Agricultural and Food Chemistry and Cell Death and Differentiation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.